Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Reversing Weight Gain Following Gastric Bypass Surgery

By HospiMedica International staff writers
Posted on 30 Jul 2009
Patients who have regained weight after gastric bypass surgery now have access to an incisionless procedure that appears highly effective at reversing weight gain, according to a new study. More...


Researchers at the University of California, San Diego (UCSD, USA) conducted a six-month follow-up of a registry of 116 patients enrolled who underwent Restorative Obesity Surgery, Endolumenal (ROSE). For the purposes of the registry, excess body weight was defined as anything over a body mass index (BMI) rating of 55. The registry data showed that 88% (96) of the patients stopped regaining weight after ROSE. Overall, these patients lost an average 18% of their excess weight six months after the procedure. Patients who were most successful losing weight after their original gastric bypass had the best results following the ROSE procedure; this subset of patients dropped 29% of their excess weight during the six months after ROSE. One of the patient in the study lost 30 kg, or 84% of her excess weight, during that six-month period. The study was presented at the annual meeting of the American Society of Metabolic and Bariatric Surgeons (ASMBS), held during July 2009 in Grapevine (TX, USA).

"We believe this registry represents the largest collection of data showing the effectiveness, safety and durability of the ROSE procedure,” said study presenter Santiago Horgan, M.D, a professor of surgery and director of the Center for the Treatment of Obesity at UCSD. "There are not many options to repair a failing gastric bypass. Invasive procedures to restore the anatomy are complicated and risky for most patients. In comparison, there were no significant complications associated with ROSE and most of the patients lost clinically relevant amounts of weight.”

Up to 50% of patients who undergo gastric bypass surgery begin to regain weight after two years; this often occurs because the stomach pouch and the stoma connecting the stomach to the small intestine slowly stretch, allowing the patient to eat more without feeling full, necessitating ROSE. The procedure avoids cutting through scar tissue, and involves inserting a small, flexible endoscope and several specially crafted tools through the mouth, down the esophagus, and into the stomach pouch; once there, the doctor can reduce the size of the stomach pouch and the opening to the intestine from the inside, without having to cut through previously damaged tissue. The tools, developed by USGI Medical (San Clemente, CA, USA), are used to grasp, fold, and stitch tissue to reduce both the diameter of the stomach opening and the volume of the stomach pouch.

Related Links:

University of California, San Diego
USGI Medical




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.